Thirty-one percent of adult Americans are not simply overweight, they are clinically diagnosed as obese. This translates into 500 million people. Obesity has become one of the most serious threats to Americans health and well-being. Figures show that obesity rates in the United states have steadily risen over the last 25 years and have reached epidemic proportions.
The health risks most commonly linked to obesity are heart attack, stroke, high blood pressure, high cholesterol, and diabetes. The annual medical costs associated with these ills are astronomical. The risk of health issues are high for those who are overweight, however, when one is obese, the chance of risk rises exponentially.
Bio-pharmaceutical group, Vivus, has developed a product, in hope of rendering a solution to this pandemic problem. The Food and Drug Administration recently announced consent, for the once daily Medication, Qsymia, commonly known as the weight loss pill.
Approval for weight loss drugs is significant in light of the fact that the FDA has not approved any drugs for weight loss in the past 10 years. Thus the weight loss pill passed FDA approval under considerable scrutiny. Qsymia is a combination drug, two drugs working together as one. Both of these drugs have enjoyed various rates of success in weight loss therapy. It was the innovative approach of Vivus to put them together.
The results from the Food and Drug Administration's clinical trials are more than convincing. The weight loss pill outperformed any other drugs that were also tested by the FDA. In one independent study; patients taking it for one year lost 6.7 percent of their body weight. In another study patients lost a reported 8.9 percent. In that same study, patients on the strongest dosage lost 11 percent of total body weight. To put it in pounds, patients reported losing as many as 22 pounds.
Researchers have determined that Qsymia is so effective because it targets two completely separate areas that cause overeating. The drugs that comprise the weight loss pill are Topiramate and Phentermine. The former is an anti-consultant, which makes the patient feel more satisfied after a meal. The latter is an appetite suppressant.
It is a scientific fact that significant weight loss lowers risk for catastrophic health concerns. Patients in the FDA studies report positive results for blood pressure, diabetic therapy and even lessening of symptoms associated with sleep apnea by the end of the trial period.
There are certain restrictions that are assigned to Qsymia by the FDA. For example, it is only approved for use in adults. It is also restricted to use only by patients who are diagnosed as clinically obese. In addition, pregnant women are prohibited from using it. This drug must be prescribed and monitored by a physician.
Forward thinking physicians and clinics nationwide have read these studies, and started programs to administer this weapon in the arsenal to fight obesity. The local provider in most areas, Equilibrium Weight Loss and Longevity Clinic, offers the drug in the form of extended-release capsules, as part of their medically supervised weight loss protocol. In the face of epidemic obesity, there is promise on the horizon.
The health risks most commonly linked to obesity are heart attack, stroke, high blood pressure, high cholesterol, and diabetes. The annual medical costs associated with these ills are astronomical. The risk of health issues are high for those who are overweight, however, when one is obese, the chance of risk rises exponentially.
Bio-pharmaceutical group, Vivus, has developed a product, in hope of rendering a solution to this pandemic problem. The Food and Drug Administration recently announced consent, for the once daily Medication, Qsymia, commonly known as the weight loss pill.
Approval for weight loss drugs is significant in light of the fact that the FDA has not approved any drugs for weight loss in the past 10 years. Thus the weight loss pill passed FDA approval under considerable scrutiny. Qsymia is a combination drug, two drugs working together as one. Both of these drugs have enjoyed various rates of success in weight loss therapy. It was the innovative approach of Vivus to put them together.
The results from the Food and Drug Administration's clinical trials are more than convincing. The weight loss pill outperformed any other drugs that were also tested by the FDA. In one independent study; patients taking it for one year lost 6.7 percent of their body weight. In another study patients lost a reported 8.9 percent. In that same study, patients on the strongest dosage lost 11 percent of total body weight. To put it in pounds, patients reported losing as many as 22 pounds.
Researchers have determined that Qsymia is so effective because it targets two completely separate areas that cause overeating. The drugs that comprise the weight loss pill are Topiramate and Phentermine. The former is an anti-consultant, which makes the patient feel more satisfied after a meal. The latter is an appetite suppressant.
It is a scientific fact that significant weight loss lowers risk for catastrophic health concerns. Patients in the FDA studies report positive results for blood pressure, diabetic therapy and even lessening of symptoms associated with sleep apnea by the end of the trial period.
There are certain restrictions that are assigned to Qsymia by the FDA. For example, it is only approved for use in adults. It is also restricted to use only by patients who are diagnosed as clinically obese. In addition, pregnant women are prohibited from using it. This drug must be prescribed and monitored by a physician.
Forward thinking physicians and clinics nationwide have read these studies, and started programs to administer this weapon in the arsenal to fight obesity. The local provider in most areas, Equilibrium Weight Loss and Longevity Clinic, offers the drug in the form of extended-release capsules, as part of their medically supervised weight loss protocol. In the face of epidemic obesity, there is promise on the horizon.
About the Author:
Are you looking to learn if Qsymia Capsules are available around you? You will have to get a doctors approval to get the Qsymia Available
No comments:
Post a Comment